These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7195790)

  • 1. Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy.
    Smith SC; Spector SL
    Chest; 1981 Jul; 80(1):103-5. PubMed ID: 7195790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effective combined therapy of selective beta 1-adrenergic antagonist and selective beta 2-adrenergic agonist in a patient with bronchial asthma and hypertrophic cardiomyopathy].
    Yukawa T; Numao T; Motojima S; Fukuda T; Ikemori R; Makino S; Shimizu T; Hayashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Apr; 22(4):318-23. PubMed ID: 6541723
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V; Ceci V; Malinconico U; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
    Furberg CD
    Drugs; 1974; 7(1):106-17. PubMed ID: 4152150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of "specific" cardiac adrenergic inhibitors on ventilatory function in bronchial asthma].
    Monteiro Trindade A; Costa Trindade J; Palma-Carlos AG
    Nouv Presse Med; 1973 Mar; 2(9):582. PubMed ID: 4145028
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of strophanthin and pindolol in patients with hypertrophic cardiomyopathy.
    Storstein L; Abrahamsen AM; Storstein O
    Eur Heart J; 1981 Aug; 2(4):297-305. PubMed ID: 6117467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental studies on the cardio-selectivity of pindolol. Studies on healthy subjects, and patients with bronchitis and asthma].
    Meier J; Baranowski E; Wagner E
    Fortschr Med; 1973 Dec; 91(34):1363-7. PubMed ID: 4764790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and differential therapy with beta sympathicolytic drugs].
    Frisch P
    Med Klin; 1975 Oct; 70(42):1682-7. PubMed ID: 241898
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of beta-blockaders].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
    [No Abstract]   [Full Text] [Related]  

  • 11. [Competitive effects of pindolol and salbutamol on airway resistance in asthmatics].
    Von Graffenried B
    Nouv Presse Med; 1978 Sep; 7(31):2717-20. PubMed ID: 30949
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA; Sax FL; Weisman HF; Porterfield J; McIntosh C; Weisfeldt ML; Snyder SH; Epstein SE
    N Engl J Med; 1989 Mar; 320(12):755-61. PubMed ID: 2537929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
    Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
    Ameredes BT; Calhoun WJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
    Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment.
    Meyer MF; Hopkins WE; Kaminsky DA
    Chest; 2003 Sep; 124(3):1160-3. PubMed ID: 12970051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.